Scott J. Rodig

Active 1996–2025

249
Papers
74,036
Citations
130
h-index
239
i10-index

Citations

Citations per year for Scott J. Rodig1905: 1 citations1976: 1 citations1978: 1 citations1989: 1 citations1996: 21 citations1997: 47 citations1998: 63 citations1999: 82 citations2000: 62 citations2001: 67 citations2002: 50 citations2003: 50 citations2004: 48 citations2005: 43 citations2006: 59 citations2007: 18 citations2008: 65 citations2009: 76 citations2010: 173 citations2011: 352 citations2012: 456 citations2013: 494 citations2014: 550 citations2015: 735 citations2016: 945 citations2017: 1,149 citations2018: 1,271 citations2019: 3,413 citations2020: 4,004 citations2021: 4,368 citations2022: 3,322 citations2023: 2,702 citations2024: 3,969 citations2025: 2,005 citations2026: 101 citations1906–1975: no citations, so these years are not shown1977: no citations, so this year is not shown1979–1988: no citations, so these years are not shown1990–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 10,710 citing papers, 28.4% of this breakdownChina: 6,302 citing papers, 16.7% of this breakdownGermany: 1,989 citing papers, 5.3% of this breakdownUnited Kingdom: 1,813 citing papers, 4.8% of this breakdownItaly: 1,681 citing papers, 4.5% of this breakdownFrance: 1,435 citing papers, 3.8% of this breakdownJapan: 1,197 citing papers, 3.2% of this breakdownCanada: 1,055 citing papers, 2.8% of this breakdownSpain: 959 citing papers, 2.6% of this breakdownAustralia: 957 citing papers, 2.5% of this breakdownSwitzerland: 907 citing papers, 2.4% of this breakdownNetherlands: 839 citing papers, 2.2% of this breakdown
0%28.4%Other 20.8%

Fields

  • Medicine58.5%
  • Biochemistry, Genetics and Molecular Biology23.7%
  • Immunology and Microbiology13.3%
  • Computer Science1.4%
  • Neuroscience1%
  • Engineering0.9%
  • Other1.2%

Topics

  • Cancer Immunotherapy and Biomarkers9.8%
  • Immunotherapy and Immune Responses5.3%
  • CAR-T cell therapy research4.9%
  • Immune Cell Function and Interaction4.7%
  • Lymphoma Diagnosis and Treatment3.3%
  • Immune cells in cancer2.6%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2019 cited by 2,072

  2. An immunogenic personal neoantigen vaccine for patients with melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dan H. Barouch, Jon C. Aster, Gad Getz, Kai W. Wucherpfennig, Donna Neuberg, Jerome Ritz, Eric S. Lander, Edward F. Fritsch, Nir Hacohen, Catherine J. Wu - Nature 2017 cited by 2,980

  3. Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

    Authors: , , , , , , - IEEE Transactions on Medical Imaging, IEEE Trans. Medical Imaging 2020 cited by 578

  4. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heather Daley, Patrick Y. Wen, E. Antonio Chiocca, Maegan Harden, Niall J. Lennon, Stacey Gabriel, Gad Getz, Eric S. Lander, Aviv Regev, Jerome Ritz, Donna Neuberg, Scott J. Rodig, Keith L. Ligon, Mario L. Suvà, Kai W. Wucherpfennig, Nir Hacohen, Edward F. Fritsch, Kenneth J. Livak, Patrick A. Ott, Catherine J. Wu, David A. Reardon - Nature 2018 cited by 1,464

  5. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Reiner Siebert, Andreas Rosenwald, Aaron R. Thorner, Matthew Meyerson, Todd R. Golub, Rameen Beroukhim, Gerald Wulf, German Ott, Scott J. Rodig, Stefano Monti, Donna Neuberg, Markus Loeffler, Michael Pfreundschuh, Lorenz Trümper, Gad Getz, Margaret A. Shipp - Nature Medicine 2018 cited by 1,972

  6. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2019 cited by 910

  7. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy

    Authors: , , , , , , , , , , , , - Genome biology 2016 cited by 2,768

  8. Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 1,570

  9. Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bradley L. Pentelute, Nir Hacohen, Kenneth J. Livak, Sachet A. Shukla, Lars Rønn Olsen, Dan H. Barouch, Kai W. Wucherpfennig, Edward F. Fritsch, Derin B. Keskin, Catherine J. Wu, Patrick A. Ott - Nature Medicine 2021 cited by 518

  10. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 3,547

  11. Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel L. Abravanel, Nikhil Wagle, Bruce E. Johnson, Johanna Klughammer, Michal Slyper, Julia Waldman, Judit Jané‐Valbuena, Orit Rozenblatt–Rosen, Aviv Regev, George M. Church, Adam Marblestone, Edward S. Boyden, H. Raza Ali, M. Al Sa’d, Shahar Alon, Samuel Aparício, Giorgia Battistoni, Shankar Balasubramanian, Robert Becker, Bernd Bodenmiller, Edward S. Boyden, Dario Bressan, Alejandra Bruna, Marcel Burger, Carlos Caldas, Maurizio Callari, Ian G. Cannell, Helen Casbolt, N. Chornay, Yi Cui, A. Dariush, K. Dinh, A. Emenari, Y. Eyal-Lubling, Jean Fan, Ali Fatemi, Edward A. Fisher, E. A. González-Solares, C. Gónzalez-Fernández, Daniel Goodwin, Wendy Greenwood, Francesco Grimaldi, Gregory J. Hannon, Opusunju Boma Harris, Shelley Harris, Cristina Jauset, Johanna A. Joyce, Emmanouil D. Karagiannis, Tatjana Kovačević, Laura Kuett, Russell Kunes, A. Yoldaş, Dongbing Lai, Emma Laks, Hsuan Lee, M. Lee, Giulia Lerda, Yuxin Li, Andrew McPherson, Neal L. Millar, Claire M. Mulvey, Fiona Nugent, Ciara H. O’Flanagan, Marta Pàez‐Ribes, I. Pearsall, Fatime Qosaj, Andrew Roth, Oscar M. Rueda, Teresa Ruíz, Kirsty Sawicka and 20 more - Science 2021 cited by 419

  12. Clinical trial links oncolytic immunoactivation to survival in glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Scott J. Rodig, Patrick Y. Wen, Eudocia Q. Lee, Lakshmi Nayak, Ugonma Chukwueke, L. Nicolas Gonzalez Castro, Sydney Dumont, Tracy T. Batchelor, Kara A. Kittelberger, Ekaterina Tikhonova, Natalia Miheecheva, D Tabakov, Nara Shin, Alisa M. Gorbacheva, Artemy Shumskiy, Felix Frenkel, Estuardo Aguilar-Córdova, Laura K. Aguilar, David Krisky, James Wechuck, Andrea G. Manzanera, Christopher Matheny, Paul P. Tak, Francesca Barone, Daniel Kovarsky, Itay Tirosh, Mario L. Suvà, Kai W. Wucherpfennig, Keith L. Ligon, David A. Reardon, E. Antonio Chiocca - Nature 2023 cited by 256

  13. Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eliezer M. Van Allen, Mizuki Nishino, Lynette M. Sholl, David C. Christiani, Xihong Lin, Scott J. Rodig, Matthew D. Hellmann, Mark M. Awad - JAMA Oncology 2022 cited by 384

  14. Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2018 cited by 610

  15. Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , F. Stephen Hodi, Myles Brown, X. Shirley Liu - Cancer Discovery 2021 cited by 282

  16. MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

    Authors: , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 584

  17. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance

    Authors: , , , , , , , , , , , , , , , , , , , - Cell stem cell 2016 cited by 531

  18. Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xitao Wang, Bowen Chen, Fangxin Hong, Lynette M. Sholl, Michael Tolstorukov, Kathleen L. Pfaff, Pasi A. Jänne, Evisa Gjini, Robin Edwards, Scott J. Rodig, Ellis L. Reinherz, Matthew G. Oser, David A. Barbie - Cancer Discovery 2021 cited by 214

  19. Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2020 cited by 347

  20. Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan D. Schoenfeld, Evisa Gjini, Ana Lako, Wade L. Thorstad, Hiram A. Gay, Mackenzie Daly, Scott J. Rodig, Ian S. Hagemann, Dorina Kallogjeri, Jay F. Piccirillo, Rebecca D. Chernock, Malachi Griffith, Obi L. Griffith, Douglas R. Adkins - Clinical Cancer Research 2020 cited by 365

  21. Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2013 cited by 1,242

  22. High-plex immunofluorescence imaging and traditional histology of the same tissue section for discovering image-based biomarkers

    Authors: , , , , , , , , , , , , , - Nature Cancer 2023 cited by 150

  23. Immunological mechanisms of the antitumor effects of supplemental oxygenation

    Authors: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 596

  24. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 193